A Study Evaluating the Association of Inflammation With Hemodialysis Access Type

NCT01011985 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2018-07-09

No results posted yet for this study

Summary

To determine if the type of hemodialysis vascular access correlates with markers of inflammation, namely C-reactive protein and interleukin-6, and with both access and patient survival in the end stage renal disease population.

Conditions

Sponsors & Collaborators

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Michele H Mokrzycki, MD, MS · Montefiore Medical Center

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2008-04-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01011985 on ClinicalTrials.gov